Amneal Pharmaceuticals is trading at $18.84, up +4.20%, alongside broad risk-on sentiment.
- The S&P 500 is up 0.91%, while the Nasdaq Composite is up 1.23%.
- No new company-specific announcement dated September 17, 2026 was identified; available coverage references older conference, FDA, acquisition, and earnings developments.
- The move follows a +8.59% gain on September 16, suggesting continued momentum rather than a newly confirmed corporate catalyst.